Free Trial

Chemours (CC) News Today

Chemours logo
$17.72 +0.25 (+1.43%)
(As of 12/20/2024 05:31 PM ET)
The Chemours Company stock logo
State Street Corp Has $92.42 Million Position in The Chemours Company (NYSE:CC)
State Street Corp lowered its holdings in The Chemours Company (NYSE:CC - Free Report) by 2.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,548,019 shares of the specialty chemicals company's stock after selling
Jefferies Reaffirms Their Hold Rating on Chemours Company (CC)
RBC Capital Sticks to Its Buy Rating for Chemours Company (CC)
The Chemours Company stock logo
Quadrature Capital Ltd Sells 23,879 Shares of The Chemours Company (NYSE:CC)
Quadrature Capital Ltd decreased its stake in shares of The Chemours Company (NYSE:CC - Free Report) by 67.3% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 11,624 shares of the specialty chemicals company's stock after selling 23,879
The Chemours Company stock logo
Two Sigma Advisers LP Increases Stock Holdings in The Chemours Company (NYSE:CC)
Two Sigma Advisers LP raised its stake in shares of The Chemours Company (NYSE:CC - Free Report) by 9.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 503,100 shares of the specialty chemicals company's s
The Chemours Company stock logo
Jacobs Levy Equity Management Inc. Purchases New Shares in The Chemours Company (NYSE:CC)
Jacobs Levy Equity Management Inc. purchased a new stake in The Chemours Company (NYSE:CC - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 120,506 shares of the specialty chemicals company's stock, valued
The Chemours Company stock logo
1,390,350 Shares in The Chemours Company (NYSE:CC) Acquired by Vision One Management Partners LP
Vision One Management Partners LP acquired a new stake in The Chemours Company (NYSE:CC - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 1,390,350 shares of the specialty chemicals company's stock, valued at approxim
The Chemours Company stock logo
Charles Schwab Investment Management Inc. Raises Position in The Chemours Company (NYSE:CC)
Charles Schwab Investment Management Inc. grew its holdings in The Chemours Company (NYSE:CC - Free Report) by 2.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,229,052 shares of the specialt
The Chemours Company stock logo
RBF Capital LLC Purchases 124,311 Shares of The Chemours Company (NYSE:CC)
RBF Capital LLC boosted its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 42.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 414,618 shares of the specialty chemicals company's
The Chemours Company stock logo
Holocene Advisors LP Acquires 177,673 Shares of The Chemours Company (NYSE:CC)
Holocene Advisors LP lifted its holdings in The Chemours Company (NYSE:CC - Free Report) by 1,058.1% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 194,465 shares of the specialty chemicals company's stock after acquiring an additional 177,673
The Chemours Company stock logo
Quantbot Technologies LP Has $233,000 Stock Position in The Chemours Company (NYSE:CC)
Quantbot Technologies LP lowered its position in shares of The Chemours Company (NYSE:CC - Free Report) by 90.7% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 11,459 shares of the specialty chemicals company's stock after selling 111,5
The Chemours Company stock logo
Erste Asset Management GmbH Invests $728,000 in The Chemours Company (NYSE:CC)
Erste Asset Management GmbH purchased a new position in The Chemours Company (NYSE:CC - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 35,142 shares of the specialty chemicals company's
The Chemours Company stock logo
The Chemours Company (NYSE:CC) Receives Average Recommendation of "Hold" from Analysts
The Chemours Company (NYSE:CC - Get Free Report) has been given a consensus rating of "Hold" by the eight analysts that are presently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company.
The Chemours Company stock logo
The Chemours Company (NYSE:CC) Short Interest Update
The Chemours Company (NYSE:CC - Get Free Report) was the target of a large decrease in short interest in November. As of November 15th, there was short interest totalling 7,280,000 shares, a decrease of 5.5% from the October 31st total of 7,700,000 shares. Based on an average daily volume of 1,550,000 shares, the short-interest ratio is currently 4.7 days. Approximately 4.9% of the shares of the stock are short sold.
The Chemours Company stock logo
ARGA Investment Management LP Grows Stake in The Chemours Company (NYSE:CC)
ARGA Investment Management LP grew its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 61.0% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 147,582 shares of the specialty chemicals company's stock after buying an additional 5
The Chemours Company stock logo
Fmr LLC Buys 618,361 Shares of The Chemours Company (NYSE:CC)
Fmr LLC boosted its stake in The Chemours Company (NYSE:CC - Free Report) by 3.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 18,142,202 shares of the specialty chemicals company's stock after purchasing an
The Chemours Company stock logo
The Chemours Company (NYSE:CC) Shares Sold by Forest Avenue Capital Management LP
Forest Avenue Capital Management LP cut its position in shares of The Chemours Company (NYSE:CC - Free Report) by 39.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 514,492 shares of the specialty chemicals company's stock af
The Chemours Company stock logo
Massachusetts Financial Services Co. MA Sells 967,691 Shares of The Chemours Company (NYSE:CC)
Massachusetts Financial Services Co. MA lessened its holdings in The Chemours Company (NYSE:CC - Free Report) by 38.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,526,108 shares of the specialty chemicals
The Chemours Company stock logo
Advisors Asset Management Inc. Acquires New Shares in The Chemours Company (NYSE:CC)
Advisors Asset Management Inc. bought a new position in shares of The Chemours Company (NYSE:CC - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 95,402 shares of the specialty chemicals company's stock, v
The Chemours Company stock logo
Victory Capital Management Inc. Acquires 69,531 Shares of The Chemours Company (NYSE:CC)
Victory Capital Management Inc. grew its stake in The Chemours Company (NYSE:CC - Free Report) by 206.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 103,259 shares of the specialty chemicals company's
The Chemours Company stock logo
Natixis Advisors LLC Sells 146,232 Shares of The Chemours Company (NYSE:CC)
Natixis Advisors LLC cut its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 27.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 377,973 shares of the specialty chemicals company's stock after sellin
The Chemours Company stock logo
The Chemours Company (NYSE:CC) Shares Sold by Principal Financial Group Inc.
Principal Financial Group Inc. trimmed its position in The Chemours Company (NYSE:CC - Free Report) by 30.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 345,916 shares of the specialty chemicals company's stock afte
The Chemours Company stock logo
Vaughan Nelson Investment Management L.P. Sells 657,560 Shares of The Chemours Company (NYSE:CC)
Vaughan Nelson Investment Management L.P. cut its stake in shares of The Chemours Company (NYSE:CC - Free Report) by 23.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,166,741 shares of the special
The Chemours Company stock logo
State of New Jersey Common Pension Fund D Buys 28,591 Shares of The Chemours Company (NYSE:CC)
State of New Jersey Common Pension Fund D lifted its stake in The Chemours Company (NYSE:CC - Free Report) by 39.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 101,670 shares of the specialty chemicals company's st
The Chemours Company stock logo
GSA Capital Partners LLP Buys New Shares in The Chemours Company (NYSE:CC)
GSA Capital Partners LLP bought a new stake in The Chemours Company (NYSE:CC - Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 79,491 shares of the specialty chemicals company's stock, valued at approximately
FMR LLC Increases Stake in The Chemours Co
Why Chemours' (NYSE:CC) Earnings Are Better Than They Seem
The Chemours Company stock logo
The Chemours Company (NYSE:CC) Receives Average Rating of "Hold" from Analysts
Shares of The Chemours Company (NYSE:CC - Get Free Report) have earned a consensus rating of "Hold" from the eight brokerages that are presently covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and three have given a buy recommen
Chemours Surges 17% On The Recent Q3 Results
The Chemours Company stock logo
Chemours (NYSE:CC) Issues Quarterly Earnings Results, Beats Expectations By $0.08 EPS
Chemours (NYSE:CC - Get Free Report) issued its quarterly earnings data on Monday. The specialty chemicals company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.32 by $0.08. The business had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.44 billion. Chemours had a net margin of 2.16% and a return on equity of 33.21%. The firm's revenue was up .9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.64 EPS.
Barclays Sticks to Their Hold Rating for Chemours Company (CC)
Get Chemours News Delivered to You Automatically

Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

CC Media Mentions By Week

CC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CC
News Sentiment

0.25

0.51

Average
Basic Materials
News Sentiment

CC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CC Articles
This Week

2

10

CC Articles
Average Week

Get Chemours News Delivered to You Automatically

Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:CC) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners